CPIVC NEWS

China's NMPA grants clinical trial approval for DIFF Biotech's DIFF-flu nasal spray influenza vaccine

2026-06-01

Link:https://www.prnewswire.com/news-releases/diff-biotechs-innovative-nasal-spray-influenza-vaccine-receives-clinical-trial-approval-introducing-a-new-attenuation-pathway-302681779.html